Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study.
作者信息
Sciascia Savino, Yazdany Jinoos, Dall'Era Maria, Fenoglio Roberta, Radin Massimo, Aggarwal Ishita, Cuadrado Maria J, Schreiber Karen, Barreca Antonella, Papotti Mauro, Roccatello Dario
机构信息
Center of Research of Immunopathology and Rare Diseases- Coordinating Center of the Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
SCU Nephrology and Dialysis(ERKnet member), S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
出版信息
Ann Rheum Dis. 2019 Jul;78(7):1004-1006. doi: 10.1136/annrheumdis-2018-214559. Epub 2018 Dec 14.
Abstract
摘要
相似文献
1
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study.合并狼疮性肾炎和血栓性微血管病患者的抗凝治疗：一项多中心队列研究。
Ann Rheum Dis. 2019 Jul;78(7):1004-1006. doi: 10.1136/annrheumdis-2018-214559. Epub 2018 Dec 14.
2
Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus.抗磷脂综合征肾病和系统性红斑狼疮患者中的其他血栓性微血管病。
Adv Chronic Kidney Dis. 2019 Sep;26(5):376-386. doi: 10.1053/j.ackd.2019.08.012.
3
[Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy].[依库珠单抗作为狼疮性肾炎相关血栓性微血管病的挽救治疗]
G Ital Nefrol. 2020 Jun 10;37(3):2020-vol3.
4
Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence.拓展狼疮性肾炎的治疗选择：依库珠单抗，现有证据
Rheumatol Int. 2017 Aug;37(8):1249-1255. doi: 10.1007/s00296-017-3686-5. Epub 2017 Mar 3.
5
Thrombotic microangiopathy with refractory lupus nephritis successfully treated by combining rituximab with belimumab.利妥昔单抗联合贝利尤单抗成功治疗难治性狼疮性肾炎伴血栓性微血管病
Scand J Rheumatol. 2023 Mar;52(2):227-229. doi: 10.1080/03009742.2022.2140483. Epub 2022 Nov 21.
6
Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study.血浆置换与狼疮性肾炎合并血栓性微血管病患者更好的肾脏结局相关：一项病例系列研究
Medicine (Baltimore). 2016 May;95(18):e3595. doi: 10.1097/MD.0000000000003595.
7
Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis.抗磷脂抗体综合征相关的肾血栓性微血管病在一名无狼疮肾炎的系统性红斑狼疮患者中，并未因利伐沙班而改善，反而因华法林而改善。
CEN Case Rep. 2021 Aug;10(3):409-413. doi: 10.1007/s13730-021-00581-2. Epub 2021 Feb 17.
8
The spectrum of renal thrombotic microangiopathy in lupus nephritis.狼疮性肾炎中肾血栓性微血管病的谱系
Arthritis Res Ther. 2013 Jan 15;15(1):R12. doi: 10.1186/ar4142.
9
A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy.系统性红斑狼疮相关性血栓性微血管病中依库珠单抗作用的系统评价。
BMC Nephrol. 2020 Jun 30;21(1):245. doi: 10.1186/s12882-020-01888-5.
10
Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab.系统性红斑狼疮中的血栓性微血管病：依库珠单抗的疗效。
Am J Kidney Dis. 2015 Jan;65(1):127-30. doi: 10.1053/j.ajkd.2014.07.031. Epub 2014 Nov 15.
引用本文的文献
1
Vascular injury in glomerulopathies: the role of the endothelium.肾小球疾病中的血管损伤：内皮的作用。
Front Nephrol. 2024 Dec 23;4:1396588. doi: 10.3389/fneph.2024.1396588. eCollection 2024.
2
II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment.巴西风湿病学会狼疮肾炎诊断与治疗共识。
Adv Rheumatol. 2024 Jun 18;64(1):48. doi: 10.1186/s42358-024-00386-8.
3
Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations.抗磷脂综合征的流行病学：大血管和微血管表现。
Rheumatology (Oxford). 2024 Feb 6;63(SI):SI24-SI36. doi: 10.1093/rheumatology/kead571.
4
Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN).狼疮性肾炎的诊断与治疗：西班牙肾小球疾病研究组（GLOSEN）共识文件总结
Clin Kidney J. 2023 Mar 22;16(9):1384-1402. doi: 10.1093/ckj/sfad055. eCollection 2023 Sep.
5
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies.肾损伤的临床病理特征可识别抗磷脂抗体患者中的不同聚类。
Kidney Int Rep. 2023 Jan 23;8(4):754-763. doi: 10.1016/j.ekir.2023.01.018. eCollection 2023 Apr.
6
COVID-19 and thrombotic microangiopathies.COVID-19 与血栓性微血管病。
Thromb Res. 2021 Jun;202:191-198. doi: 10.1016/j.thromres.2021.04.012. Epub 2021 Apr 20.
本文引用的文献
1
Effect of Thrombotic Microangiopathy on Clinical Outcomes in Indian Patients With Lupus Nephritis.血栓性微血管病对印度狼疮性肾炎患者临床结局的影响。
Kidney Int Rep. 2017 Apr 27;2(5):844-849. doi: 10.1016/j.ekir.2017.04.008. eCollection 2017 Sep.
2
Prognostic significance of renal vascular pathology in lupus nephritis.狼疮性肾炎中肾血管病理的预后意义
Lupus. 2017 Sep;26(10):1042-1050. doi: 10.1177/0961203317692419. Epub 2017 Feb 8.
3
Renal involvement in antiphospholipid syndrome.抗磷脂综合征的肾脏受累。
Nat Rev Nephrol. 2014 May;10(5):279-89. doi: 10.1038/nrneph.2014.38. Epub 2014 Mar 18.
4
Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis.抗磷脂抗体与狼疮性肾炎患者慢性肾功能不全风险增加相关。
Am J Kidney Dis. 2004 Jan;43(1):28-36. doi: 10.1053/j.ajkd.2003.09.011.
Zotero 插件